Nikolay Savchuk

CIK: 0002017800

Transaction Breakdown

Open Market Buys (P)2 (22.2%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (55.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (22.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TRAW

Traws Pharma, Inc.

DirectorOfficer

NONE

Lomond Therapeutics Holdings, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

TRAW
Traws Pharma, Inc.
Jul 9, 2026
Award(A)
Stock Option (right to buy)
Direct
93K shares-
TRAW
Traws Pharma, Inc.
Mar 8, 2026
Award(A)
Stock Option (right to buy)
Direct
96.9K shares-
TRAW
Traws Pharma, Inc.
Dec 12, 2025
Award(A)
Direct
16.4K shares-
TRAW
Traws Pharma, Inc.
Oct 12, 2025
Award(A)
Stock Option (right to purchase)
Direct
22.4K shares-
TRAW
Traws Pharma, Inc.
Dec 29, 2024
Purchase(P)
Pre-Funded Warrant (right to buy)
Indirect
96.3K shares-
TRAW
Traws Pharma, Inc.
Dec 29, 2024
Purchase(P)
Series A Warrant (right to buy)
Indirect
96.3K shares-
No ticker
Lomond Therapeutics Holdings, Inc.
Nov 1, 2024
Award(A)
Indirect
1.4M shares at avg. $4.00$5.8M
No ticker
Lomond Therapeutics Holdings, Inc.
Nov 1, 2024
Conversion(C)
Indirect
694.4K shares at avg. $3.60$2.5M
No ticker
Lomond Therapeutics Holdings, Inc.
Nov 1, 2024
Conversion(C)
Indirect
539.1K shares at avg. $3.20$1.7M

		Type	Shares	Price		Ownership
Jul 9, 2026	TRAW Traws Pharma, Inc.	Award(A) Stock Option (right to buy)	93,000	-	-	Direct
Mar 8, 2026	TRAW Traws Pharma, Inc.	Award(A) Stock Option (right to buy)	96,899	-	-	Direct
Dec 12, 2025	TRAW Traws Pharma, Inc.	Award(A)	16,419	-	-	Direct
Oct 12, 2025	TRAW Traws Pharma, Inc.	Award(A) Stock Option (right to purchase)	22,435	-	-	Direct
Dec 29, 2024	TRAW Traws Pharma, Inc.	Purchase(P) Pre-Funded Warrant (right to buy)	96,348	-	-	Indirect
Dec 29, 2024	TRAW Traws Pharma, Inc.	Purchase(P) Series A Warrant (right to buy)	96,348	-	-	Indirect
Nov 1, 2024	No ticker Lomond Therapeutics Holdings, Inc.	Award(A)	1,443,750	$4.00	$5,775,000	Indirect
Nov 1, 2024	No ticker Lomond Therapeutics Holdings, Inc.	Conversion(C)	694,444	$3.60	$2,499,998	Indirect
Nov 1, 2024	No ticker Lomond Therapeutics Holdings, Inc.	Conversion(C)	539,062	$3.20	$1,724,998	Indirect

1-9 of 9 transactions

About Savchuk Nikolay

Savchuk Nikolay (SEC CIK 0002017800) files insider reports with the SEC as Chief Operating Officer of Traws Pharma, Inc. (TRAW) and President and COO of Lomond Therapeutics Holdings, Inc.

Signal8 holds 7 ownership filings by Savchuk Nikolay (1 Form 3, 6 Form 4), filed between Nov 5, 2024 and Jul 15, 2026. Those filings report 9 transactions, from Nov 1, 2024 to Jul 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Savchuk Nikolay's filings is in NEWTOWN, PA.

Recent filings by Savchuk Nikolay

Jul 9, 2026: Grant or award of TRAW derivative securities (Form 4, code A).
Mar 8, 2026: Grant or award of TRAW derivative securities (Form 4, code A).
Dec 12, 2025: Grant or award of TRAW shares (Form 4, code A).
Oct 12, 2025: Grant or award of TRAW derivative securities (Form 4, code A).
Dec 29, 2024: Open-market purchases of TRAW derivative securities (2 lines, Form 4, code P).

Other insiders filing for Traws Pharma, Inc. (TRAW)

Pauza Charles David, Chief Science Officer Virology
CAUTREELS WERNER, Director
STOVER JACK E, Director
Dukes Iain D., Chief Executive Officer
Redfield Robert, Chief Medical Officer
Parker Charles Nolan, Chief Financial Officer

How to read Form 4 transaction codes